LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $173,281,267

Key CONT_AWD_75N91023F00008_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 45 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91023F00008_7529_75N91019D00024_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91023F00008_7529_75N91019D00024_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:54:21Z

Content hash 05d0c740c8d27b167eaa794459613dcb073f439b4815dc3b71f86defd0ce4989

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$173,281,267	first version	June 1, 2023	July 22, 2026	2026-09-05T00:54:21Z	historical sweep	`05d0c740c8d2`

Archived copy

https://web.archive.org/web/20261008173600/https://www.usaspending.gov/award/CONT_AWD_75N91023F00008_7529_75N91019D00024_7529 captured by this system, October 8, 2026

What the amount is made of

5 recorded actions, so the amount is the award's current total across all of them. 3 of them obligated money. Measured 2026-10-13, when USAspending reported a total obligation of $173,281,267.

Action date	Modification	Type	Obligated	Description as recorded
July 22, 2026	P00004	OTHER ADMINISTRATIVE ACTION	no money	NIAID DMID NEXT GENERATION COVID VACCINE TRIAL
June 26, 2025	P00003	OTHER ADMINISTRATIVE ACTION	−$119,352,799	EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
April 24, 2025	P00002	TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL)	no money	EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
January 17, 2024	P00001	OTHER ADMINISTRATIVE ACTION	+$15,048,720	THE OBJECTIVE OF THIS TASK ORDER SUPPORTS NIAIDS GOAL TO CONDUCT A SERIES OF STANDARDIZED PHASE 1 AND PHASE 2 TRIALS ON NEXT-GENERATION VACCINES TO GENERATE DATA TO INFORM DECISIONS ON WHICH CANDIDATES TO SUPPORT FOR ADVANCED DEVELOPMENT.
June 1, 2023	base	not on file	+$277,585,346	THE OBJECTIVE OF THIS TASK ORDER SUPPORTS NIAIDS GOAL TO CONDUCT A SERIES OF STANDARDIZED PHASE 1 AND PHASE 2 TRIALS ON NEXT-GENERATION VACCINES TO GENERATE DATA TO INFORM DECISIONS ON WHICH CANDIDATES TO SUPPORT FOR ADVANCED DEVELOPMENT.

Last refreshed November 4, 2026 at 2:31 PM UTC.